Stericycle (NASDAQ:SRCL) released its quarterly earnings data on Thursday. The business services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.02, Briefing.com reports. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. The company had revenue of $854.90 million for the quarter, compared to analyst estimates of $856.36 million. During the same period in the prior year, the company posted $1.10 EPS. The company’s revenue was down 3.2% compared to the same quarter last year. Stericycle updated its FY 2018 guidance to $4.31-4.41 EPS and its FY18 guidance to $4.31-4.41 EPS.
NASDAQ SRCL traded down $3.47 during trading hours on Friday, reaching $47.31. 4,278,847 shares of the company’s stock were exchanged, compared to its average volume of 990,418. The firm has a market cap of $4.29 billion, a PE ratio of 11.15, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. Stericycle has a one year low of $46.44 and a one year high of $76.73. The company has a debt-to-equity ratio of 0.87, a current ratio of 0.81 and a quick ratio of 0.81.
Several research firms have recently weighed in on SRCL. Bank of America lowered their price objective on Stericycle from $53.00 to $50.00 and set an “underperform” rating on the stock in a research note on Friday. Robert W. Baird lowered their price objective on Stericycle from $70.00 to $56.00 and set a “neutral” rating on the stock in a research note on Friday. Northcoast Research reiterated a “neutral” rating on shares of Stericycle in a research note on Friday, October 12th. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating in a research note on Tuesday, October 9th. Finally, Barrington Research set a $72.00 price target on Stericycle and gave the stock a “buy” rating in a research report on Friday, October 5th. Five analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $66.88.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SRCL. Whittier Trust Co. grew its position in Stericycle by 362.6% during the 2nd quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock worth $129,000 after acquiring an additional 852 shares during the last quarter. Zions Bancorporation bought a new stake in Stericycle during the 3rd quarter worth approximately $130,000. Dupont Capital Management Corp grew its position in Stericycle by 102.2% during the 2nd quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock worth $136,000 after acquiring an additional 1,056 shares during the last quarter. NumerixS Investment Technologies Inc grew its position in Stericycle by 285.0% during the 2nd quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock worth $174,000 after acquiring an additional 1,995 shares during the last quarter. Finally, Intact Investment Management Inc. bought a new stake in Stericycle during the 2nd quarter worth approximately $202,000. Institutional investors and hedge funds own 94.57% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
See Also: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.